Title:
USE OF A MATRIX FOR REMOVING C-REACTIVE PROTEIN FROM BIOLOGICAL LIQUIDS
Document Type and Number:
WIPO Patent Application WO2007076844
Kind Code:
B1
Abstract:
The invention relates to a method for treating the risk of accumulating C-reactive protein (CRP) by performing an extracorporeal perfusion of blood plasma of patients presenting a risk of cardiovascular diseases or immune dysfunctions such as autoimmune diseases by means of an apparatus, e.g. a column, which contains absorbent matrix material including lipids, peptides, polypeptides, phosphocholine (PC), or PC derivatives, in order to eliminate C-reactive protein. The invention further relates to the use of compounds which have the property of at least temporarily binding CRP in order to eliminate CRP from a patient's biological liquids so as to prevent and/or treat autoimmune diseases, cardiovascular diseases such as myocardial infarction, stroke, diabetes, rheumatism, and renal insufficiency.
More Like This:
Inventors:
VOGT BIRGIT (DE)
Application Number:
PCT/DE2006/002335
Publication Date:
October 11, 2007
Filing Date:
December 22, 2006
Export Citation:
Assignee:
BETA V3 GMBH (DE)
VOGT BIRGIT (DE)
VOGT BIRGIT (DE)
International Classes:
A61M1/36; A61K35/14; A61K35/16; B01J20/22
Download PDF: